FDA
-
-
-
-
-
-
-
SAB Biotherapeutics (SABS) PT Raised to $13 at Jefferies
-
-
-
-
-
-
-
Cuprina gets FDA clearance for first Lucilia cuprina maggot therapy
-
-
-
-
-
-
-
Sensei Biotherapeutics changes name to Faeth Therapeutics
-
-
-
-
-
-
-
Spruce Biosciences names Eric Jordan VP of marketing, Tina Gullotta VP of finance
-
-
-
-
-
-
-
Lexeo finalizes pivotal trial design for gene therapy in heart condition
-
-
-
-
-
-
-
Crinetics reports two-year PALSONIFY acromegaly treatment data
-
-
-
-
-
-
-
Crinetics presents CAH trial data for atumelnant at ENDO 2026
-
323,153 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

